​

Senti Biosciences (SNTI) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChart

SNTI Stock Rating

Senti Biosciences stock's rating consensus is Buy, based on 4 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 2 Buy (50.00%), 2 Hold (50.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 4 0 2 2 Strong Sell Sell Hold Buy Strong Buy

SNTI Price Target Upside V Benchmarks

TypeNameUpside
StockSenti Biosciences-
SectorHealthcare Stocks 19.91%
IndustryBiotech Stocks 55.52%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$1.70$1.70$1.70
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jul, 2511---2
Jun, 25-1---1
May, 25-1---1
Mar, 25-1---1
Feb, 25-1---1
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jun 06, 2025LaidlawBuyinitialise

Financial Forecast

EPS Forecast

$-25 $-20 $-15 $-10 $-5 $0 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$-22.29$-16.01$-11.49--
Avg Forecast$-1.64$-17.50$-14.54$-1.88$-5.80
High Forecast$-1.64$-17.50$-14.54$-1.88$-5.80
Low Forecast$-1.64$-17.50$-14.54$-1.88$-5.80
Surprise %1259.15%-8.51%-20.98%--

Revenue Forecast

$3M $3M $4M $4M $5M $5M Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$4.29M$2.56M---
Avg Forecast$4.05M$3.46M$2.80M$5.00M$3.80M
High Forecast$4.05M$3.46M$2.80M$5.00M$3.80M
Low Forecast$4.05M$3.46M$2.80M$5.00M$3.80M
Surprise %5.91%-26.00%---

Net Income Forecast

$-95M $-77M $-59M $-41M $-23M $-5M Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$-58.21M$-92.92M$-52.79M--
Avg Forecast$-7.28M$-77.65M$-64.52M$-8.34M$-25.74M
High Forecast$-7.28M$-77.65M$-64.52M$-8.34M$-25.74M
Low Forecast$-7.28M$-77.65M$-64.52M$-8.34M$-25.74M
Surprise %699.25%19.66%-18.18%--

SNTI Forecast FAQ

Is Senti Biosciences stock a buy?

Senti Biosciences stock has a consensus rating of Buy, based on 4 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 2 Buy, 2 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Senti Biosciences is a favorable investment for most analysts.

What is Senti Biosciences's price target?

Senti Biosciences's price target, set by 4 Wall Street analysts, averages - over the next 12 months. The price target range spans from - at the low end to - at the high end, suggesting a potential 0% change from the previous closing price of $1.7.

How does Senti Biosciences stock forecast compare to its benchmarks?

Senti Biosciences's stock forecast shows a 0% downside, underperforming the average forecast for the healthcare stocks sector (19.91%) and underperforming the biotech stocks industry (55.52%).

What is the breakdown of analyst ratings for Senti Biosciences over the past three months?

  • July 2025: 50.00% Strong Buy, 50.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • June 2025: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • May 2025: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Senti Biosciences’s EPS forecast?

Senti Biosciences's average annual EPS forecast for its fiscal year ending in December 2025 is $-1.88, marking a -83.64% decrease from the reported $-11.49 in 2024. Estimates for the following years are.

What is Senti Biosciences’s revenue forecast?

Senti Biosciences's average annual revenue forecast for its fiscal year ending in December 2025 is $5M, reflecting a 0% decrease from the reported $0 in 2024. The forecast for.

What is Senti Biosciences’s net income forecast?

Senti Biosciences's net income forecast for the fiscal year ending in December 2025 stands at $-8.342M, representing a -84.20% decrease from the reported $-52.79M in 2024. Projections indicate .